PT - JOURNAL ARTICLE AU - Chunxue Bai AU - Sanjay H. Chotirmall AU - Jordi Rello AU - George A. Alba AU - Leo C. Ginns AU - Jerry A. Krishnan AU - Robert Rogers AU - Elisabeth Bendstrup AU - Pierre-Regis Burgel AU - James D. Chalmers AU - Abigail Chua AU - Kristina A. Crothers AU - Abhijit Duggal AU - Yeon Wook Kim AU - John G. Laffey AU - Carlos M. Luna AU - Michael S. Niederman AU - Ganesh Raghu AU - Julio A. Ramirez AU - Jordi Riera AU - Oriol Roca AU - Maximiliano Tamae-Kakazu AU - Antoni Torres AU - Richard R. Watkins AU - Miriam Barrecheguren AU - Mirko Belliato AU - Hassan A. Chami AU - Rongchang Chen AU - Gustavo A. Cortes-Puentes AU - Charles Delacruz AU - Margaret M. Hayes AU - Leo M.A. Heunks AU - Steven R. Holets AU - Catherine L. Hough AU - Sugeet Jagpal AU - Kyeongman Jeon AU - Takeshi Johkoh AU - May M. Lee AU - Janice Liebler AU - Gerry N. McElvaney AU - Ari Moskowitz AU - Richard A. Oeckler AU - Iñigo Ojanguren AU - Anthony O'Regan AU - Mathias W. Pletz AU - Chin Kook Rhee AU - Marcus J. Schultz AU - Enrico Storti AU - Charlie Strange AU - Carey C. Thomson AU - Francesca J. Torriani AU - Xun Wang AU - Wim Wuyts AU - Tao Xu AU - Dawei Yang AU - Ziqiang Zhang AU - Kevin C. Wilson TI - Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated International Task Force (29 July 2020) AID - 10.1183/16000617.0287-2020 DP - 2020 Sep 30 TA - European Respiratory Review PG - 200287 VI - 29 IP - 157 4099 - http://err.ersjournals.com/content/29/157/200287.short 4100 - http://err.ersjournals.com/content/29/157/200287.full SO - EUROPEAN RESPIRATORY REVIEW2020 Sep 30; 29 AB - Background Coronavirus disease 2019 (COVID-19) is a disease caused by severe acute respiratory syndrome-coronavirus-2. Consensus suggestions can standardise care, thereby improving outcomes and facilitating future research.Methods An International Task Force was composed and agreement regarding courses of action was measured using the Convergence of Opinion on Recommendations and Evidence (CORE) process. 70% agreement was necessary to make a consensus suggestion.Results The Task Force made consensus suggestions to treat patients with acute COVID-19 pneumonia with remdesivir and dexamethasone but suggested against hydroxychloroquine except in the context of a clinical trial; these are revisions of prior suggestions resulting from the interim publication of several randomised trials. It also suggested that COVID-19 patients with a venous thromboembolic event be treated with therapeutic anticoagulant therapy for 3 months. The Task Force was unable to reach sufficient agreement to yield consensus suggestions for the post-hospital care of COVID-19 survivors. The Task Force fell one vote shy of suggesting routine screening for depression, anxiety and post-traumatic stress disorder.Conclusions The Task Force addressed questions related to pharmacotherapy in patients with COVID-19 and the post-hospital care of survivors, yielding several consensus suggestions. Management options for which there is insufficient agreement to formulate a suggestion represent research priorities.For patients with acute COVID-19 pneumonia who require oxygen support, the International Task Force made suggestions for remdesivir and dexamethasone, but against hydroxychloroquine. Post-discharge management of COVID-19 survivors is a research priority. https://bit.ly/32B96uI